164 related articles for article (PubMed ID: 35645805)
1.
Yu X; Zhu X; Zhang L; Qin JJ; Feng C; Li Q
Front Pharmacol; 2022; 13():883581. PubMed ID: 35645805
[TBL] [Abstract][Full Text] [Related]
2. Redifferentiation of radioiodine-refractory thyroid cancers.
Buffet C; Wassermann J; Hecht F; Leenhardt L; Dupuy C; Groussin L; Lussey-Lepoutre C
Endocr Relat Cancer; 2020 May; 27(5):R113-R132. PubMed ID: 32191916
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis and targeted therapies for radioiodine refractory thyroid cancer.
Yu Q; Zhang X; Li L; Zhang C; Huang J; Huang W
Asia Pac J Clin Oncol; 2023 Jun; 19(3):279-289. PubMed ID: 35950297
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics reveals the implication of acetoacetate and ketogenic diet therapy in radioiodine-refractory differentiated thyroid carcinoma.
Wang J; Xu Q; Xuan Z; Mao Y; Tang X; Yang K; Song F; Zhu X
Oncologist; 2024 May; ():. PubMed ID: 38760956
[TBL] [Abstract][Full Text] [Related]
5. The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and
Anekpuritanang T; Uataya M; Claimon A; Laokulrath N; Pongsapich W; Pithuksurachai P
Onco Targets Ther; 2021; 14():3959-3969. PubMed ID: 34234465
[TBL] [Abstract][Full Text] [Related]
6. Functional Radionuclide Imaging, In-Vitro Radioiodine Uptake Estimation and RT-PCR in the Evaluation of Sodium Iodide Symporter (NIS) Expression and Functionality in Breast Cancer: A Pilot Study.
Joseph JK; Patel RB; Damle AA; Nair N; Badwe RA; Basu S
Indian J Surg Oncol; 2013 Mar; 4(1):80-91. PubMed ID: 24426705
[TBL] [Abstract][Full Text] [Related]
7. Curcumin enhances the membrane trafficking of the sodium iodide symporter and augments radioiodine uptake in dedifferentiated thyroid cancer cells
Zhang L; Xu S; Cheng X; Wu J; Wang X; Wu L; Yu H; Bao J
Food Funct; 2021 Sep; 12(18):8260-8273. PubMed ID: 34323243
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol.
Iravani A; Solomon B; Pattison DA; Jackson P; Ravi Kumar A; Kong G; Hofman MS; Akhurst T; Hicks RJ
Thyroid; 2019 Nov; 29(11):1634-1645. PubMed ID: 31637953
[No Abstract] [Full Text] [Related]
9. MAPK Inhibition Requires Active RAC1 Signaling to Effectively Improve Iodide Uptake by Thyroid Follicular Cells.
Faria M; Domingues R; Bugalho MJ; Matos P; Silva AL
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34831012
[TBL] [Abstract][Full Text] [Related]
10. Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets.
Spitzweg C; Bible KC; Hofbauer LC; Morris JC
Lancet Diabetes Endocrinol; 2014 Oct; 2(10):830-42. PubMed ID: 24898835
[TBL] [Abstract][Full Text] [Related]
11. Induction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cells.
Liu Z; Xing M
PLoS One; 2012; 7(2):e31729. PubMed ID: 22359623
[TBL] [Abstract][Full Text] [Related]
12. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
[TBL] [Abstract][Full Text] [Related]
13. Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.
Fletcher A; Read ML; Thornton CEM; Larner DP; Poole VL; Brookes K; Nieto HR; Alshahrani M; Thompson RJ; Lavery GG; Landa I; Fagin JA; Campbell MJ; Boelaert K; Turnell AS; Smith VE; McCabe CJ
Cancer Res; 2020 Jan; 80(1):102-115. PubMed ID: 31672844
[TBL] [Abstract][Full Text] [Related]
14. Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.
Hou P; Bojdani E; Xing M
J Clin Endocrinol Metab; 2010 Feb; 95(2):820-8. PubMed ID: 20008023
[TBL] [Abstract][Full Text] [Related]
15. Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer.
Shang H; Zhao J; Yao J; Wang H; Dong J; Liao L
Front Oncol; 2020; 10():404. PubMed ID: 32300552
[TBL] [Abstract][Full Text] [Related]
16. Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.
Singh TD; Jeong SY; Lee SW; Ha JH; Lee IK; Kim SH; Kim J; Cho SJ; Ahn BC; Lee J; Jeon YH
J Nucl Med; 2015 Nov; 56(11):1690-6. PubMed ID: 26338896
[TBL] [Abstract][Full Text] [Related]
17. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells.
Zhang H; Chen D
Thyroid Res; 2018; 11():13. PubMed ID: 30337961
[TBL] [Abstract][Full Text] [Related]
19. Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib.
Jafri S; Yaqub A
Cureus; 2021 Aug; 13(8):e17488. PubMed ID: 34595070
[TBL] [Abstract][Full Text] [Related]
20. Platelet-Derived Growth Factor Receptor-α Subunit Targeting Suppresses Metastasis in Advanced Thyroid Cancer
Lin CL; Tsai ML; Chen YH; Liu WN; Lin CY; Hsu KW; Huang CY; Chang YJ; Wei PL; Chen SH; Huang LC; Lee CH
Biomol Ther (Seoul); 2021 Sep; 29(5):551-561. PubMed ID: 34031270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]